Neuronal ceroid lipofuscinoses: Many players, and more to come

Alessandro Simonati, Natalia Cannelli, Francesco Pezzini, Chiara Aiello, Marzia Bianchi, Alessandra Tessa, Filippo M. Santorelli

Research output: Contribution to journalArticle

Abstract

The neuronal ceroid lipofuscinoses (NCL) are the most common group of progressive neurodegenerative diseases of childhood. The overall clinical features are highly similar regardless of the age at disease manifestation, the extent and shape of abnormally stored cytosomes and the severity of clinical course, and are generally characterized by failure and regression of psychomotor development, impaired vision, seizures and fatal outcome. The expanding array of genetic etiologies and disease-associated mutations in NCL provide the basis for the heterogeneity of these clinical conditions and are the focus of this review. Less understood are the pathogenic mechanisms, but common themes and molecular pathways are now emerging and new players are expected to come into the scene of NCL.

Original languageEnglish
Pages (from-to)601-616
Number of pages16
JournalFuture Neurology
Volume4
Issue number5
DOIs
Publication statusPublished - 2009

Fingerprint

Neuronal Ceroid-Lipofuscinoses
Inborn Genetic Diseases
Fatal Outcome
Neurodegenerative Diseases
Seizures
Mutation

Keywords

  • Cytosome
  • Genetic heterogeneity
  • Lysosomal disease
  • Mutations
  • NCL

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Simonati, A., Cannelli, N., Pezzini, F., Aiello, C., Bianchi, M., Tessa, A., & Santorelli, F. M. (2009). Neuronal ceroid lipofuscinoses: Many players, and more to come. Future Neurology, 4(5), 601-616. https://doi.org/10.2217/fnl.09.38

Neuronal ceroid lipofuscinoses : Many players, and more to come. / Simonati, Alessandro; Cannelli, Natalia; Pezzini, Francesco; Aiello, Chiara; Bianchi, Marzia; Tessa, Alessandra; Santorelli, Filippo M.

In: Future Neurology, Vol. 4, No. 5, 2009, p. 601-616.

Research output: Contribution to journalArticle

Simonati, A, Cannelli, N, Pezzini, F, Aiello, C, Bianchi, M, Tessa, A & Santorelli, FM 2009, 'Neuronal ceroid lipofuscinoses: Many players, and more to come', Future Neurology, vol. 4, no. 5, pp. 601-616. https://doi.org/10.2217/fnl.09.38
Simonati, Alessandro ; Cannelli, Natalia ; Pezzini, Francesco ; Aiello, Chiara ; Bianchi, Marzia ; Tessa, Alessandra ; Santorelli, Filippo M. / Neuronal ceroid lipofuscinoses : Many players, and more to come. In: Future Neurology. 2009 ; Vol. 4, No. 5. pp. 601-616.
@article{6307c006f48343c18e0e85f239c1dbef,
title = "Neuronal ceroid lipofuscinoses: Many players, and more to come",
abstract = "The neuronal ceroid lipofuscinoses (NCL) are the most common group of progressive neurodegenerative diseases of childhood. The overall clinical features are highly similar regardless of the age at disease manifestation, the extent and shape of abnormally stored cytosomes and the severity of clinical course, and are generally characterized by failure and regression of psychomotor development, impaired vision, seizures and fatal outcome. The expanding array of genetic etiologies and disease-associated mutations in NCL provide the basis for the heterogeneity of these clinical conditions and are the focus of this review. Less understood are the pathogenic mechanisms, but common themes and molecular pathways are now emerging and new players are expected to come into the scene of NCL.",
keywords = "Cytosome, Genetic heterogeneity, Lysosomal disease, Mutations, NCL",
author = "Alessandro Simonati and Natalia Cannelli and Francesco Pezzini and Chiara Aiello and Marzia Bianchi and Alessandra Tessa and Santorelli, {Filippo M.}",
year = "2009",
doi = "10.2217/fnl.09.38",
language = "English",
volume = "4",
pages = "601--616",
journal = "Future Neurology",
issn = "1479-6708",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Neuronal ceroid lipofuscinoses

T2 - Many players, and more to come

AU - Simonati, Alessandro

AU - Cannelli, Natalia

AU - Pezzini, Francesco

AU - Aiello, Chiara

AU - Bianchi, Marzia

AU - Tessa, Alessandra

AU - Santorelli, Filippo M.

PY - 2009

Y1 - 2009

N2 - The neuronal ceroid lipofuscinoses (NCL) are the most common group of progressive neurodegenerative diseases of childhood. The overall clinical features are highly similar regardless of the age at disease manifestation, the extent and shape of abnormally stored cytosomes and the severity of clinical course, and are generally characterized by failure and regression of psychomotor development, impaired vision, seizures and fatal outcome. The expanding array of genetic etiologies and disease-associated mutations in NCL provide the basis for the heterogeneity of these clinical conditions and are the focus of this review. Less understood are the pathogenic mechanisms, but common themes and molecular pathways are now emerging and new players are expected to come into the scene of NCL.

AB - The neuronal ceroid lipofuscinoses (NCL) are the most common group of progressive neurodegenerative diseases of childhood. The overall clinical features are highly similar regardless of the age at disease manifestation, the extent and shape of abnormally stored cytosomes and the severity of clinical course, and are generally characterized by failure and regression of psychomotor development, impaired vision, seizures and fatal outcome. The expanding array of genetic etiologies and disease-associated mutations in NCL provide the basis for the heterogeneity of these clinical conditions and are the focus of this review. Less understood are the pathogenic mechanisms, but common themes and molecular pathways are now emerging and new players are expected to come into the scene of NCL.

KW - Cytosome

KW - Genetic heterogeneity

KW - Lysosomal disease

KW - Mutations

KW - NCL

UR - http://www.scopus.com/inward/record.url?scp=75249095276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75249095276&partnerID=8YFLogxK

U2 - 10.2217/fnl.09.38

DO - 10.2217/fnl.09.38

M3 - Article

AN - SCOPUS:75249095276

VL - 4

SP - 601

EP - 616

JO - Future Neurology

JF - Future Neurology

SN - 1479-6708

IS - 5

ER -